News Chart Altimmune, Inc.

Equities

ALT

US02155H2004

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-01-16 EST			5-day change	1st Jan Change
4.240 ^USD	0.00%		+5.47%	+17.45%

01-05	Altimmune, Inc. Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH	CI
01-05	Altimmune Says US FDA Grants Breakthrough Therapy Designation for Pemvidutide in MASH	MT

92b9665692e1b264c89eb82167e.miklpxZHjLWYt2V2smDDjRfDfdWRI2GE_uv3gg-QKs8.11BUz1Um6NTM1Qc50yG1yXaiEaTiZwTQkq3C-DvPTJCrR03gRGrC5v7DAg~9049f6dd3356158f4a6dfb543ac1ceda